SSShachi Srivatsa

Shachi Srivatsa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shachi Srivatsa has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Jennifer H. Aldrink

    Division of Pediatric Surgery, Department of Surgery, Nationwide Children's Hospital The Ohio State University College of Medicine Columbus Ohio USA

    5 shared publications
  • Kyle J. Van Arendonk

    Center for Surgical Outcomes Research, Nationwide Children’s Hospital, Columbus, Ohio, USA

    4 shared publications
  • Sara A. Mansfield

    Division of Pediatric Surgery, Department of Surgery, Nationwide Children’s Hospital, The Ohio State University College of Medicine, Columbus, USA

    3 shared publications
  • Amelia Gavulic

    Division of Pediatric Surgery, Department of Surgery Nationwide Children's Hospital, The Ohio State University College of Medicine Columbus Ohio USA

    2 shared publications
  • Beth Rymeski

    Division of Pediatric General and Thoracic Surgery, Department of Surgery Cincinnati Children's Hospital Cincinnati Ohio USA

    2 shared publications
  • Daniel S. Eiferman

    The Ohio State University Wexner Medical Center

    2 shared publications

Latest Publications

  • Open Access

    Segmentectomy or Lobectomy for Early-Stage Lung Cancer? A Patient-Centered Framework for Surgical Decision-Making

    by Shachi Srivatsa, Peter J. Kneuertz

    Randomized trials have established segmentectomy and sublobar resection as oncologically appropriate alternatives to lobectomy for selected patients with small, peripheral, node-negative non-small cell lung cancer (NSCLC). These findings have expanded surgical options but also shifted the clinical question from whether sublobar resection is adequate to how the extent of resection should be individualized. Patients considering lung cancer surgery want to know: What provides the best chance of cure? How safe is the operation? How will surgery affect breathing and quality of life? What will recovery look like? And which operation is right for them? These questions provide the framework for this review. We examine the evidence needed to address each question, including oncologic outcomes and recurrence, tumor location and achievable margins, lymph node assessment, radiographic and biologic tumor characteristics, perioperative outcomes, preservation of pulmonary function, quality of life, and postoperative recovery. Long-term considerations include competing risks of mortality, the development of second primary lung cancers, and preservation of treatment options for future lung disease. The relative importance of these factors differs among patients and may alter the balance between oncologic control and parenchymal preservation. This review provides a patient-centered framework for integrating tumor characteristics, operative considerations, functional outcomes, and patient factors to individualize the choice between segmentectomy and lobectomy for early-stage NSCLC.

  • Open Access

    Reducing barriers to pediatric surgical care: a cross-sectional study of the importance of a rural close-to-home clinic

    by Katherine C. Bergus, Shachi Srivatsa, Skyler Kalady, Kyle J. Van Arendonk, Sara A. Mansfield

  • Open Access

    Postoperative Care and Management in Pediatric Hematology‐Oncology Patients

    by Shachi Srivatsa, Sara A. Mansfield

    Pediatric patients with hematologic and oncologic diseases often undergo surgical procedures as part of diagnosis and therapy. These include central venous catheter placements, tumor resections, lymph node and bone marrow biopsies, among others. Optimal postoperative care in this vulnerable population is critical, as children receiving chemotherapy or stem cell transplantation are immunocompromised and at high risk for infections, bleeding, and other complications. This review provides a comprehensive overview of common pediatric hemato‐oncologic surgeries and detailed postoperative management strategies. A thorough, multidisciplinary postoperative plan is essential for pediatric hematology‐oncology patients to minimize morbidity, avoid delays in adjuvant therapy, and ultimately enhance survival and quality of life.

  • Open Access

    Resource utilization and surgical risk in pediatric pneumatosis intestinalis

    by Shachi Srivatsa, Megan Read, Taha Akbar, Swapna Koppera, Melissa Hamrick, Joshua Gadelsayed, Jennifer H. Aldrink, Kyle J. Van Arendonk


  • Open Access

    Surgical Outcomes of Acute Mastoiditis in Pediatric Patients: A Pediatric Health Information System Study

    by Shachi Srivatsa, Brenna Rachwal, Taha Akbar, Nicholas Pennza, Lindsey Asti, Peter C. Minneci, Prashant Malhotra, Prasanth Pattisapu

    Objective: To evaluate outcomes of surgically treated acute mastoiditis (AM) in pediatric patients using the Pediatric Health Information System (PHIS). Study Design: Retrospective cohort study. Setting: Pediatric tertiary care centers participating in the PHIS. Methods: Children aged 0 to 18 years with AM treated from January 1, 2016, to December 31, 2022, were identified using International Classification of Diseases, Tenth Revision, Clinical Modifications (ICD‐10) codes and categorized by surgical treatment: mastoidectomy alone, myringotomy with mastoidectomy (MMT), or myringotomy alone. Primary outcomes were length of stay (LOS) and 90‐day all‐cause readmission. Complicated AM was defined via diagnosis codes indicating disease extension beyond the middle ear/mastoid. Multivariable regression models adjusting for patient and hospital‐level variables assessed associations. Cohort validation was performed through chart review. Results: Among 1368 patients, 637 (46.6%) underwent myringotomy alone, 153 (11.2%) mastoidectomy alone, and 578 (42.3%) MMT. Complicated AM was present in 62.3%, most frequently in patients receiving mastoidectomy alone (76.5%) or MMT (77.9%). Median LOS was longer in the mastoidectomy group (5 days) compared to MMT (4 days) and myringotomy alone (3 days; P < .0001). In adjusted models, mastoidectomy (incident rate ratio [IRR]: 1.20, 95% CI: 1.07‐1.34) and MMT (IRR: 1.10, 95% CI: 1.02‐1.18) were associated with longer LOS. Ninety‐day readmissions occurred in 9.3% of patients, highest in the mastoidectomy group (14.4%; P = .027). Intensive care unit (ICU) admission (adjusted odds ratio [aOR]: 3.98, 95% CI: 2.34‐6.77), hematologic/immunologic conditions (aOR: 3.17, 95% CI: 1.85‐5.43), and malignancy (aOR: 7.94, 95% CI: 3.91‐16.12) were predictors of readmission. Conclusion: This multi‐institutional study shows that surgical approach and disease severity correlate with pediatric AM outcomes. Findings support using validated administrative data in studying AM outcomes, addressing limitations of prior literature.

  • Helicopter Transport of Trauma Patients Continues to be Overutilized: A Call for Universal Transport Criterion

    by Shachi Srivatsa, Mehak Chawla, Marlene Hernandez, Grace Mallampalli, Angela Duff, Ghee Rye Lee, Emily Frucci, Daniel S. Eiferman

    Background: Helicopter emergency medical services (HEMS) provide rapid transport for trauma patients to specialized centers, potentially improving outcomes in life-threatening situations. However, HEMS is costly and often overutilized, with limited benefit in low-acuity cases. This study re-evaluates HEMS utilization at our Level I trauma center to assess current appropriateness based on clinical need and validated triage criteria. Methods: We retrospectively analyzed all trauma patients transported to our institution by helicopter from January 2018-December 2021. Patients were categorized into trauma activation criteria and if any procedural intervention was performed within 1 hour of transport. Of the patients that received a procedure during admission, type of procedure and specialty that performed the procedure were evaluated. Disposition from trauma bay was collected. Results: 1419 helicopter transports met inclusion criteria during our analyzed time frame. 37.8% (n = 536) required a procedural intervention during their admission. Only 1.5% of patients (n = 21) who received an intervention were treated within 1 hour of arrival. Less than 30% of patients met criteria for helicopter transport when evaluated with current established national guidelines for prehospital triage. 35% of patients required ICU admission, while 8% were discharged to home within 24 hours. 36.3% (n = 515) of patients were activated as a Level I trauma alert upon arrival. Conclusions: Most helicopter transports were not clinically justified based on urgency or national triage guidelines. These findings highlight persistent overuse of HEMS and reinforce the need for standardized, evidence-based criteria to guide both scene and interfacility helicopter transport decisions in trauma care.


  • Optimizing surveillance strategies for sacrococcygeal teratoma: A Midwest pediatric surgery consortium multi‐institutional study

    by Shachi Srivatsa, Lindsay Gil, Yueran Zhang, Beth Rymeski, Amelia Gavulic, Grace Mak, Sindhu V. Mannava, Troy A. Markel, Matthew P. Landman, Dave R. Lal, et al.

    Sacrococcygeal teratomas (SCTs) are the most common germ cell tumors in neonates and infants. While typically benign, SCTs carry an undefined risk of recurrence and malignant transformation, making post‐resection surveillance critical. However, no consensus guidelines exist to direct post‐resection surveillance. We conducted a multi‐institutional retrospective cohort study across 11 pediatric institutions in the Midwest Pediatric Surgery Research Consortium. The study included patients 18 years or younger who underwent SCT resection from January 2010 to December 2020, excluding those with Currarino syndrome. The primary outcome was SCT recurrence, assessed via clinical exams, imaging, and tumor markers. Secondary outcomes included recurrence histology and surveillance practices. Cox proportional hazards modeling evaluated recurrence risk factors. Of the 178 patients, 10% experienced recurrence during a median follow‐up period of 2.88 years (IQR: 1.52, 4.80). Overall recurrence‐free survival for the entire cohort was 93.7%, 88.8%, and 88.8% at 1, 3, and 5 years, respectively. Malignant histopathology was the only factor significantly associated with recurrence (HR 5.83, p = .014). The timing of SCT diagnosis, completeness of resection, and Altman classification were not significantly associated with recurrence. Surveillance strategies varied significantly across institutions, with no standardized protocol for follow‐up. The majority of recurrences occurred within the first 3 years post‐resection, with malignant histopathology being the strongest predictor. For lower risk tumors (mature and immature teratomas), a minimum of 3 years of surveillance, including imaging, tumor markers, and clinical exams, is recommended. Standardized surveillance protocols could improve consistency and early detection.


  • Sacrococcygeal Teratomas in Currarino Syndrome: A Multicenter Review of Tumor Characteristics, Surgical Outcomes, and Recurrence

    by Shachi Srivatsa, Lindsay Gil, Yueran Zhang, Beth Rymeski, Amelia Gavulic, Grace Mak, Sindhu V. Mannava, Troy A. Markel, Matthew P. Landman, Dave R. Lal, et al.


  • Implementation of an Enhanced Recovery Pathway for Pediatric Single Lobe Thyroidectomy

    by Shachi Srivatsa, Lauren Parrish, Cindy McManaway, Vanessa Ng, Joseph D. Tobias, Katherine Manupipatpong, Kris R. Jatana, Jennifer H. Aldrink


  • Open Access

    Reevaluating Surgical Antibiotic Prophylaxis in Pediatric Pyloromyotomy: Insights From the NSQIP-Pediatric Database

    by Shachi Srivatsa, Megan Read, Brenna Rachwal, Yueran Zhang, Kristine Griffin, Sara Mansfield, Kyle Van Arendonk